No black box warning on record for Welireg

As of the latest FDA labeling reviewed, Welireg (BELZUTIFAN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Welireg medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Anemia : Monitor for anemia before initiation of and periodically throughout treatment with WELIREG. Withhold WELIREG until hemoglobin ≥8g/dL, then resume at the same or reduced dose or discontinue. For life threatening anemia, or for anemia requiring urgent intervention, withhold WELIREG until hemoglobin ≥8g/dL and resume at a reduced dose or permanently discontinue WEL

No black box warning on record for Welireg

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Anemia : Monitor for anemia before initiation of and periodically throughout treatment with WELIREG. Withhold WELIREG until hemoglobin ≥8g/dL, then resume at the same or reduced dose or discontinue. For life threatening anemia, or for anemia requiring urgent intervention, withhold WELIREG until hemoglobin ≥8g/dL and resume at a reduced dose or permanently discontinue WEL

Welireg Black Box Warning

No black box warning on record for Welireg

Other warnings & precautions

Welireg Black Box Warning

No black box warning on record for Welireg

Other warnings & precautions